###begin article-title 0
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Decorin </italic>
###xml 12 20 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 20 22 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 20 22 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
Decorin and TGF-beta1 polymorphisms and development of COPD in a general population
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 57 65 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 65 67 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 65 67 62 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 119 127 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 127 129 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 127 129 121 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 324 332 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 336 344 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 344 346 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 344 346 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 381 383 372 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 381 383 372 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
Decorin, an extracellular matrix (ECM) proteoglycan, and TGF-beta1 are both involved in lung ECM turnover. Decorin and TGF-beta1 expression are decreased respectively increased in COPD lung tissue. Interestingly, they act as each other's feedback regulator. We investigated whether single nucleotide polymorphisms (SNPs) in decorin and TGF-beta1 underlie accelerated decline in FEV1 and development of COPD in the general population.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 220 228 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 228 230 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 228 230 225 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 445 447 442 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
We genotyped 1390 subjects from the Vlagtwedde/Vlaardingen cohort. Lung function was measured every 3 years for a period of 25 years. We tested whether five SNPs in decorin (3'UTR and four intron SNPs) and three SNPs in TGF-beta1 (3'UTR rs6957, C-509T rs1800469 and Leu10Pro rs1982073), and their haplotypes, were associated with COPD (last survey GOLD stage = II). Linear mixed effects models were used to analyze genotype associations with FEV1 decline.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 82 90 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 90 92 87 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 90 92 87 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 297 305 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 305 307 299 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 305 307 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 401 409 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 409 411 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 409 411 400 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 444 446 435 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 463 470 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin</italic>
###xml 507 515 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 515 517 503 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 515 517 503 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 521 529 509 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 590 592 578 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
We found a significantly higher prevalence of carriers of the minor allele of the TGF-beta1 rs6957 SNP (p = 0.001) in subjects with COPD. Additionally, we found a significantly lower prevalence of the haplotype with the major allele of rs6957 and minor alleles for rs1800469 and rs1982073 SNPs in TGF-beta1 in subjects with COPD (p = 0.030), indicating that this association is due to the rs6957 SNP. TGF-beta1 SNPs were not associated with FEV1 decline. SNPs in decorin, and haplotypes constructed of both TGF-beta1 and decorin SNPs were not associated with development of COPD or with FEV1 decline.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 98 106 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 106 108 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 106 108 103 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 189 197 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 197 199 191 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 197 199 191 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 258 260 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Our study shows for the first time that SNPs in decorin on its own or in interaction with SNPs in TGF-beta1 do not underlie the disturbed balance in expression between these genes in COPD. TGF-beta1 SNPs are associated with COPD, yet not with accelerated FEV1 decline in the general population.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 164 166 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 175 176 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 517 525 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 525 527 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 525 527 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 584 585 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 586 587 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 629 635 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 700 708 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 708 710 696 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 708 710 696 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 799 800 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 678 686 <span type="species:ncbi:9606">patients</span>
###xml 885 893 <span type="species:ncbi:9606">patients</span>
Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airway obstruction and persistent airway inflammation. Transforming growth factor-beta1 (TGF-beta1) is one of the important cytokines involved in this inflammatory process, which has been associated with cell proliferation and differentiation. It is furthermore involved in repair of the extracellular matrix (ECM) after inflammation and tissue injury amongst others by promoting synthesis of elastin and collagen. Studies have shown that TGF-beta1 expression is increased in the airways of COPD patients [1,2] In contrast, a recent article from Pons et al showed that alveolar macrophages from COPD patients release less TGF-beta1 in response to lipopolysaccharide than smokers with normal lung function and non-smokers[3] This may lead to a reduced anti-inflammatory and anti-elastolytic response in COPD patients, subsequently contributing to progressive ECM destruction.
###end p 11
###begin p 12
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 336 344 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 344 346 341 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 344 346 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 445 453 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 453 454 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 453 454 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 456 457 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 516 524 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 524 526 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 524 526 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 565 573 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 573 575 561 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 573 575 561 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 654 655 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 806 814 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 814 816 799 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 814 816 799 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 876 878 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 890 896 875 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 908 916 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 916 918 898 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 916 918 898 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1120 1121 1102 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1305 1313 1287 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1313 1315 1292 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1313 1315 1292 1294 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1345 1353 1324 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1353 1355 1329 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1353 1355 1329 1331 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
###xml 768 776 <span type="species:ncbi:9606">patients</span>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
###xml 1048 1056 <span type="species:ncbi:9606">patients</span>
###xml 1089 1097 <span type="species:ncbi:9606">patients</span>
###xml 1214 1222 <span type="species:ncbi:9606">patients</span>
Decorin is a component of the ECM that regulates collagen fibrillogenesis. [4-6] In addition, it can interact with a wide variety of growth factors, cytokines and adhesion molecules through its extensive binding area, thereby not only playing a role in ECM assembly but also in control of cell proliferation and tissue morphogenesis.[7]TGF-beta1 has been shown to downregulate synthesis of decorin in fibroblasts and decorin can in turn inhibit TGF-beta1.[8] Decorin may thus act as a negative feedback regulator of TGF-beta1 mediated repair responses. Conversely, TGF-beta1 can downregulate expression of decorin in fibroblasts from emphysema patients.[9] We have shown previously that decorin expression is diminished in the peribronchiolar area of lung tissue from patients with severe emphysema, while TGF-beta1 production from fibroblasts of these patients is increased.[10] Noordhoek et al showed that TGF-beta1 and basic fibroblast growth factor give a stronger reduction of decorin production in the culture supernatant of fibroblasts from patients with severe emphysema than from patients with mild emphysema. [9] It thus appears that the regulation of decorin production is disturbed in lung tissue from patients with severe emphysema. This will lead to diminished binding and neutralization of TGF-beta1 by decorin followed by higher TGF-beta1 concentrations and activity with lower decorin production as a result.
###end p 12
###begin p 13
###xml 54 62 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 62 64 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 62 64 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 68 76 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 256 264 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 264 266 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 264 266 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 283 291 277 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
We hypothesized that the reciprocal regulation of the TGF-beta1 and decorin genes is disturbed in COPD due to a genetic mutation in one or both of these genes. We have tested this hypothesis by investigating three single nucleotide polymorphisms (SNPs) in TGF-beta1 and five SNPs in decorin on the development of COPD and on lung function decline in a large cohort derived from the general population (the Vlagtwedde/Vlaardingen cohort).
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Subjects
###end title 15
###begin p 16
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 697 714 697 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">additional file 1</xref>
###xml 994 998 988 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1075 1079 1067 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1209 1221 <span type="species:ncbi:9606">participants</span>
We used data from 2467 subjects of the Vlagtwedde/Vlaardingen cohort participating in the last survey in 1989/1990. This general population-based cohort of Caucasians of Dutch descent started in 1965. Surveys, during which pulmonary function measurements were performed, were held every three years. The selection of the cohort has been described previously. [11-13] Surveys were performed every 3 years during which information was collected on respiratory symptoms, smoking status, age and gender by the Dutch version of the British Medical Council standardized questionnaire. A blood sample was taken and spirometry was performed. Details on pulmonary function measurements are provided in the additional file 1. The methodology for standardization and equipment used for lung function measurements was the same throughout the study. In 1989/1990 neutrophil depot of centrifuged blood was collected and stored at -20degreesC. In 2003/2004 DNA was extracted from these samples with the QiaAmp(R) DNA Blood Mini Kit and checked for purity and concentration with the NanoDrop(R) ND-1000 UV-Vis Spectrophotometer. The study protocol was approved by the local university hospital's medical ethics committee and participants gave written informed consent.
###end p 16
###begin title 17
Genotyping
###end title 17
###begin p 18
###xml 181 189 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 189 190 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 189 190 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 300 302 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 303 305 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 322 330 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 646 648 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 972 989 969 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">additional file 1</xref>
###xml 1036 1053 1033 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">additional file 2</xref>
We genotyped DNA of those subjects with more than 1500 ng isolated DNA available (N = 1390). Three SNPs, previously associated with COPD or level of lung function were genotyped in TGF-beta1: rs6957 in the 3'UTR, rs1800469 in the promoter region (C-509T) and a coding SNP rs1982073 (Leu10Pro, G/T). [14-16] Coding SNPs in decorin have been identified in the NCBI and Celera databases, but are only prevalent in African populations (frequency 0.05-0.12) but not in Caucasian populations (frequency 0.00). According to the HapMap database there are two large LD blocks in the decorin gene, and a region including the 3'UTR that forms no LD block. [17]. There are 4 haplotype tagging SNPs located in introns, resulting in 3 major haplotypes, which cover the information of the gene. Therefore, we genotyped one SNP in the 3'UTR (rs1803343), and the 4 haplotype-tagging SNPs: rs11106030, rs741212, rs566806, rs516115 and rs3138241. The genotyping protocol is described in the additional file 1; the characteristics of the genotyped SNPs in additional file 2. To determine whether the SNPs were in Hardy Weinberg equilibrium and whether they were in linkage disequilibrium, tests were performed with the statistical package R (version 1.9.1).
###end p 18
###begin title 19
Statistics
###end title 19
###begin p 20
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 480 482 480 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 489 490 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
We identified subjects with COPD using the GOLD criteria (GOLD stage II or higher, i.e. FEV1/VC< 70% and FEV1<80% predicted) at the last survey[18] Characteristics of subjects with and without COPD at the last survey are presented in table 1. Differences in allele frequencies and haplotype frequencies between subjects with and without COPD were tested using Chi-square tests. We used ANOVA and linear regression models to study the effect of SNPs on first and last available FEV1 and FEV1/VC (adjusted for gender, age, pack-years, and height in regression models).
###end p 20
###begin p 21
Characteristics of genotyped subjects in the 1989/1990 survey
###end p 21
###begin p 22
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Abbreviations: FEV1, forced expiratory volume in 1 second; VC, vital capacity
###end p 22
###begin p 23
###xml 80 88 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 88 90 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 88 90 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 94 102 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 115 117 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 179 181 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 182 184 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 245 246 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 277 279 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 365 367 362 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 456 458 453 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 931 933 928 930 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1032 1038 1029 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1072 1080 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1080 1082 1074 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1080 1082 1074 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1190 1192 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1232 1240 1226 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1240 1242 1231 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1240 1242 1231 1233 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1251 1259 1242 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
Linear Mixed Effect (LME) models were used to investigate the effect of SNPs in TGF-beta1 and decorin on annual FEV1 decline in the general population, like published previously.[19,20] Time was defined as time in years relative to the first FEV1, starting from the age of 30.[21] Variables included in the model were age at entry, gender, pack-years, the first FEV1 after age 30, and their interaction with time. Since including the level of the first FEV1 after age 30 and its interaction with time could introduce bias due to regression to the mean, these variables were also included in the model as random effect variables. The results of these analyses showed no change in estimates of the variables in the model or a better fit of the model, which indicates that there was no bias due to regression-to-the-mean. Therefore, the results are presented without these random effects. To test whether SNPs were associated with FEV1 decline within subjects with COPD, we performed LME analyses on these subjects only. Since Celedon et al found stronger linkage results of TGF-beta1 SNPs and lung function in smokers only, we additionally performed LME models stratified to smoking status. [14] We also included interaction terms of TGF-beta1 SNPs and decorin SNPs to test for genetic interaction of these SNPs.
###end p 23
###begin p 24
###xml 385 387 385 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 450 452 450 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 583 585 583 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Instead of performing pre- or post-hoc power analysis and correction for multiple testing, we performed permutation tests to assess whether our results might have been found due to chance. Genotypes were randomly shuffled among individuals to produce 3000 datasets. The LME models were rerun on each of these datasets to generate a distribution of the beta estimates for additional FEV1 decline of the homozygous minor allele genotype compared to FEV1 decline of the homozygous wild type allele genotype under the null hypothesis, being no association of the SNPs under study and FEV1 decline. If the observed beta estimate from the true data is found in the lower 5% percentile of the empiric cumulative distribution (p < 0.05), one can assume that the observed beta estimate is not found due to chance.
###end p 24
###begin p 25
###xml 18 26 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 26 28 23 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 26 28 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 149 157 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 157 159 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 157 159 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 255 263 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 263 264 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 263 264 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 270 277 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin</italic>
###xml 545 547 536 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
We also estimated TGF-beta1 haplotype frequencies in the whole population and in subjects with a COPD phenotype. Estimated haplotype frequencies for TGF-beta1 higher than 1% in the general population were used to construct phased multi-locus genotypes of TGF-beta1. For decorin, we constructed the phased multi-locus genotypes as known from the HapMap database. With Chi-square tests we determined for each haplotype whether there was a difference in prevalence of carriers between subjects with and without COPD. Also, the excess decline in FEV1 in the whole population was determined for each phased multi-locus genotype in the LME.
###end p 25
###begin p 26
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Statistical analyses were performed using SPSS (version 12.0.1 for Windows), the statistical package R (version 1.9.1) and Arlequin [22].
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 49 57 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 57 59 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 57 59 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 63 71 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 178 188 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;1 </italic>
###xml 233 241 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 387 395 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 395 397 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 395 397 386 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 527 535 518 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 649 666 640 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">additional file 3</xref>
Allelic frequencies for the minor alleles of the TGF-beta1 and decorin SNPs in this population were comparable to those reported in the Celera and/or in the NCBI dbSNP database: TGF-beta1 rs6957 0.18, rs1800469 0.28, rs1982073 0.38, decorin rs1803343 0.02, rs11106030 0.06, rs741212 0.12, rs566806 0.26, rs516115 0.22 and rs3138241 0.06. All SNPs were in Hardy Weinberg equilibrium. The TGF-beta1 rs1800469 SNP was in significant LD with rs1982073 and rs6957. Rs6957 was in almost significant LD with rs1982072 (p = 0.06). The decorin SNPs were in significant LD. Graphs of the LD patterns with D', r and P-values in both genes are presented in the additional file 3.
###end p 28
###begin title 29
###xml 37 45 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 45 47 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 45 47 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 51 59 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
Prevalence of SNPs and haplotypes in TGF-beta1 and decorin in COPD and control subjects
###end title 29
###begin p 30
###xml 24 34 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;1 </italic>
###xml 136 137 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 150 158 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 158 160 152 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 158 160 152 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 236 244 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
The distribution of the TGF-beta1 rs6957 genotypes was significantly different between subjects with and without COPD (p = 0.001, table 2). The other TGF-beta1 SNPs were not associated with COPD. We also found no association of SNPs in decorin with the prevalence of COPD.
###end p 30
###begin p 31
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 94 96 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Prevalence of genotypes according to COPD phenotype (GOLD stage II or higher; FEV1/VC<70%, FEV1 <80% predicted).
###end p 31
###begin p 32
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 124 132 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 132 133 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 132 133 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 166 167 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Abbreviations: COPD, Chronic Obstructive Pulmonary Disease; FEV1, forced expiratory volume in 1 second; VC, vital capacity; TGF-beta1, transforming growth factor-beta1; df, degrees of freedom
###end p 32
###begin p 33
###xml 103 111 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 111 112 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 111 112 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 163 171 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 171 173 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 171 173 165 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 210 218 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 218 220 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 218 220 209 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 384 392 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 392 394 380 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 392 394 380 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 504 512 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 512 514 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 512 514 497 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 598 606 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 606 608 588 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 606 608 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 781 789 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 824 825 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 900 908 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 908 910 887 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 908 910 887 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 914 922 893 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
We used estimated haplotype frequencies higher than 0.01 to construct phased multi-locus genotypes for TGF-beta1. The haplotype consisting of the minor allele for TGF-beta1 rs6957 and the wild type alleles for TGF-beta1 rs1800469 and rs1982073 was more prevalent in subjects with COPD (p = 0.014). Because the prevalence of carriers of other haplotypes containing the minor allele at TGF-beta1 rs6957 was also increased in subjects with COPD, this finding only reflects the individual association of the TGF-beta1 rs6957 SNP with COPD. Carriers of at least one haplotype with the minor alleles for TGF-beta1 rs1800469 and rs1982073 and the wild-type allele for rs6957 were less prevalent in COPD (p = 0.030). We found no significant associations of phased multi-locus genotypes in decorin with the prevalence of COPD (table 3). We also did not find associations of haplotypes containing SNPs of both TGF-beta1 and decorin with COPD (data not shown).
###end p 33
###begin p 34
###xml 14 22 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 22 24 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 22 24 19 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 28 36 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 110 111 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 123 125 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Prevalence of TGF-beta1 and decorin haplotypes in subjects with and without COPD (GOLD stage II or higher; FEV1/VC<70%, FEV1 <80% predicted).
###end p 34
###begin p 35
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 124 132 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 132 133 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 132 133 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
Abbreviations: COPD, Chronic Obstructive Pulmonary Disease; FEV1, forced expiratory volume in 1 second; VC, vital capacity; TGF-beta1, transforming growth factor-beta1
###end p 35
###begin p 36
* 0 means wild-type; 1 means minor allele
###end p 36
###begin p 37
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
# P value of Chi-square test for difference in prevalence of haplotype between subjects with and without COPD
###end p 37
###begin title 38
Lung function
###end title 38
###begin p 39
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 265 267 265 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 349 357 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 357 359 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 357 359 354 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 363 371 360 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 498 500 495 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 679 687 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 687 689 681 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 687 689 681 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 692 700 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 746 747 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 780 788 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 788 790 779 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 788 790 779 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 793 801 784 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 940 948 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 948 950 936 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 948 950 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 953 961 941 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 1182 1183 1170 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1188 1205 1176 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">additional file 4</xref>
We found no significant associations (i.e. cross-sectional) between the SNPs tested and FEV1 and FEV1/VC at the first or at the last survey in linear regression models (data not shown). The mean adjusted annual decline in lung function (expressed as decrease in FEV1 in ml/yr) was determined for subjects with the wild-type genotype for the SNPs in TGF-beta1 and decorin using LME models. The outcome of the mean annual decline concerns females with age 30 when entered in the LME, a mean first FEV1 of the population, and zero pack-years. The mean of these adjusted annual declines was 19.2 ml/yr (range 18.7-19.6). We did not find any significant association of SNPs in either TGF-beta1 or decorin with accelerated lung function decline (table 4). We added interaction terms of TGF-beta1 en decorin SNPs in the model, but found no significant interactions. In addition, we did not find any significant association of haplotypes of either TGF-beta1 or decorin with accelerated lung function decline (results not shown). We also tested whether SNPs were associated with lung function decline within subjects with COPD or within smokers, but found no significant associations (table 4 and additional file 4). To test whether results were not missed due to chance, we performed permutation tests. We ran 3000 permutations on our sample of 1390 subjects and performed LME analyses on each of these permutations. The lack of associations with lung function decline was confirmed in these analyses.
###end p 39
###begin p 40
###xml 21 23 21 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 49 57 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 57 59 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 57 59 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 63 70 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin</italic>
###xml 197 198 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 210 211 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Annual decline in FEV1 according to genotypes of TGF-beta1 and decorin. Changes in decline between genotypes in the total population and in subjects who developed COPD (GOLD stage II or higher; FEV1/VC<70%, FEV1<80% predicted) are presented.
###end p 40
###begin p 41
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 59 67 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 67 68 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 67 68 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 101 102 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Abbreviations: FEV1, forced expiratory volume in 1 second; TGF-beta1, transforming growth factor-beta1; COPD, Chronic Obstructive Pulmonary Disease; WT, wild-type
###end p 41
###begin p 42
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 47 49 47 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 175 177 170 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
*decline in FEV1 adjusted for gender, first FEV1 after age 30 years, pack-years, and age; dagger P value indicates significance of the effect of the genotype on decline in FEV1 compared to wild-type
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 12 20 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 20 22 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 20 22 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 214 222 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 226 234 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 234 236 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 234 236 228 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 387 395 381 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 551 553 542 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 667 675 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 679 687 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 687 689 675 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 687 689 675 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 713 715 701 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 815 823 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 823 825 808 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 823 825 808 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 829 837 814 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 954 962 939 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 962 964 944 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 962 964 944 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 993 1001 975 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1001 1003 980 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1001 1003 980 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1087 1095 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1095 1097 1071 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1095 1097 1071 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1195 1203 1171 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1203 1205 1176 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1203 1205 1176 1178 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1222 1224 1195 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1230 1231 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Decorin and TGF-beta1 can act as each other's feed back regulators in ECM turnover and their expression is respectively decreased and increased in lung tissue of COPD patients. We assessed whether polymorphisms in decorin and TGF-beta1 are associated with the development of COPD and accelerated lung function decline in the general population. This is the first study assessing SNPs in decorin and we did not find any association with COPD or lung function loss. Contrary to our hypothesis, the observed disturbed balance between decorin and TGB-beta1 in COPD is not caused by a combination of SNPs in their genes, since we found no significant interaction terms of decorin and TGF-beta1 SNPs with respect to FEV1 decline. Moreover, we found no associations of phased multi-locus genotypes containing SNPs of both TGF-beta1 and decorin with the presence of GOLD stage II and III COPD in our population. This disturbed balance may be affected by SNPs in TGF-beta1 alone since the 3'UTR SNP in TGF-beta1 is predictive of COPD (stage GOLD II). We found, however, no association of SNPs in TGF-beta1 with longitudinal decline in lung function. In addition, no associations were observed of SNPs in TGF-beta1 with level of FEV1 or FEV1/VC cross-sectionally.
###end p 44
###begin p 45
###xml 41 49 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 49 51 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 49 51 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 81 89 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 89 91 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 89 91 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 152 154 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 174 176 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 183 184 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 276 278 270 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 424 426 418 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 502 504 496 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
It is puzzling that we observed that the TGF-beta1 rs6957 SNP and a haplotype in TGF-beta1 were associated with COPD, but not with excess decline in FEV1 or with level of FEV1 and FEV1/VC at the last survey. We have tested whether there were differences in first available FEV1 (which might suggest a relation to maximal attained lung function level) between the genotypes that could explain the lack of association with FEV1 decline but this was not the case. Another possibility would be that the FEV1 decline is only affected by SNPs in certain subgroups, such as smokers. Our stratified analyses showed no such effect.
###end p 45
###begin p 46
###xml 34 42 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 42 44 39 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 42 44 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 150 152 147 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 170 171 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 177 179 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 400 401 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 404 406 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 407 409 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 425 427 416 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 719 721 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 722 724 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 746 751 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 854 862 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 862 864 850 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 862 864 850 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 943 945 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 946 948 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1060 1061 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1125 1126 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1305 1313 1293 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 1313 1315 1298 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 1313 1315 1298 1300 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 1441 1443 1426 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1444 1446 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 688 696 <span type="species:ncbi:9606">patients</span>
###xml 1091 1099 <span type="species:ncbi:9606">patients</span>
Although the functionality of the TGF-beta1 rs6957 SNP is not known yet, it has previously been associated with lower pre- and post-bronchodilator FEV1 and with lower FEV1/FVC.[14] Similarly, we have shown here that this SNP is associated with development of COPD. Various studies have indicated that the rs1800469 and rs1982073 SNPs are functional and result in higher levels of circulating TGF-beta1. [23-26] Since TGF-beta1 has anti-inflammatory and pro-repair activities, these SNPs are thought to be protective against the development of COPD. Indeed, we and others have found that (carriers of haplotypes of) the minor alleles of these SNPs are significantly less prevalent in COPD patients compared to controls.[14,16]. Similar to Celedon et al, we found an association of a haplotype with at least one minor allele of the rs1800469 and rs1982073 TGF-beta1 SNPs and COPD, while they also found associations with these SNPs separately. [14,16] The differences in study populations may explain these dissimilarities, e.g. our subjects had milder COPD (FEV1<80% predicted) than the COPD patients in the Celedon study (FEV1<45% predicted). Despite the differences in associations, it is still conceivable that carrying both of the SNPs decreases the risk to develop COPD. The two other studies linking TGF-beta1 SNPs and COPD have also demonstrated that these SNPs are less prevalent in COPD, though these studies did not test haplotypes[15,16]
###end p 46
###begin p 47
###xml 37 45 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 45 47 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 45 47 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 189 197 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 197 199 191 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 197 199 191 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 254 256 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 263 264 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 294 296 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 297 299 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 337 345 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 345 347 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 345 347 336 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 432 438 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 456 458 447 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 646 648 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
Many SNPs have been described in the TGF-beta1 gene, but only a few have been intensively studied in genetic association studies. Cross-sectional studies have found associations of SNPs in TGF-beta1 with the presence of COPD, and with lower levels of FEV1 and FEV1/FVC in several populations. [14-16] We did not analyze every SNP in the TGF-beta1 gene that was previously reported to be associated with COPD. However, since Celedon et al found strong LD (r2 = 0.98) between promoter SNPs and 3'UTR SNPs in a Caucasian population, we are confident that any association that might exist would have been revealed by the SNPs or by their haplotypes.[14]
###end p 47
###begin p 48
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 421 429 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 429 431 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 429 431 426 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 958 966 955 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 1244 1252 1241 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
This is the first study on SNPs in decorin in a general population or in COPD patients. We were interested in polymorphisms in this gene, since decorin expression in COPD patients is diminished.[9,10] Decorin plays a direct role in the repair processes after inflammation through its regulation of matrix metalloproteases and tissue inhibitors of metalloproteases.[27,28] Furthermore, decorin is the natural inhibitor of TGF-beta1 and may therefore influence the repair process in the lung indirectly. We hypothesized that these processes may be genetically influenced. Since the coding SNPs in decorin described in the NCBI and Celera databases were not prevalent in Caucasians (but only in African populations), we genotyped four tagging SNPs, located in introns, and additionally a 3'UTR SNP. Although we found no significant associations of these SNPs with COPD or lung function decline, we can not rule out completely that there is no genetic defect in decorin that increases the risk to develop COPD. However, since we selected tagging SNPs that cover the genetic information of the decorin gene according to HapMap and given the large population under study, we assume that we would have observed an association of SNPs or haplotypes in decorin if there existed one in this population.
###end p 48
###begin p 49
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 832 840 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 840 842 837 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 840 842 837 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
The lack of a genetic association of SNPs in the decorin gene does not rule out an important role of the decorin protein in COPD development. Decorin is a member of the proteoglycan family, a family of macromolecules composed of a protein core with glycosaminoglycan side chains which are produced post-translationally. It is possible that the function or activation of decorin is disrupted through an altered posttranslational modification of this glycosaminoglycan chain. In this case, modifications in the protein core, which might be caused by SNPs, may not be important and will not be detected. Decorin can be expressed in six splice variants, but the function of these splice variants is not known yet. Nevertheless, a shift in prevalence of one of these splice variants may affect the biological role that decorin exerts in TGF-beta1 regulation, thereby influencing the pathology within the lung.
###end p 49
###begin title 50
Conclusion
###end title 50
###begin p 51
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 222 230 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 230 232 227 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 230 232 227 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 330 331 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 372 380 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 380 382 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 380 382 374 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 597 605 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 605 607 596 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 605 607 596 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
Contrary to our hypothesis, we were not able to identify the decorin gene as a genetic risk factor for the development of COPD. Consequently, SNPs in decorin do not seem to underlie a disturbed regulation of this gene and TGF-beta1 resulting in COPD, nor can they be held responsible for the development of COPD and decline in FEV1in the general population. We found that TGF-beta1 SNPs are associated with the development of COPD but not with accelerated lung function decline or other lung function measures in the general population. Together with previous findings, this study establishes the TGF-beta1 gene as a risk factor for the development of COPD.
###end p 51
###begin title 52
Competing interest statement
###end title 52
###begin p 53
The author(s) declare that they have no competing interests.
###end p 53
###begin title 54
Authors' contributions
###end title 54
###begin p 55
Every author contributed to reviewing of the paper. CCD performed the lab work, statistical analyses and drafted the manuscript. DSP is co principal investigator of the project, obtained funding of and supervised the project, and helped draft the manuscript. JMV contributed to the statistical analyses. MB contributed to the lab work. IMN contributed to the statistical analyses. HMB is co principal investigator of the project, obtained funding of and supervised the project, and helped draft the manuscript. All authors read and approved the final manuscript.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Additional File 1
###end title 57
###begin p 58
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methods</bold>
Methods. Detailed description of the pulmonary function protocol and the genotyping protocol
###end p 58
###begin p 59
Click here for file
###end p 59
###begin title 60
Additional File 2
###end title 60
###begin p 61
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characteristics of genotyped SNPs</bold>
Characteristics of genotyped SNPs. Table with specifications of the genotyped SNPs, i.e. location, characteristics and sequences of primers and probes.
###end p 61
###begin p 62
Click here for file
###end p 62
###begin title 63
Additional File 3
###end title 63
###begin p 64
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin </italic>
###xml 46 54 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 54 55 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 54 55 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
Linkage Disequilibrium of SNPs in decorin and TGF-beta1.
###end p 64
###begin p 65
Click here for file
###end p 65
###begin title 66
Additional File 4
###end title 66
###begin p 67
###xml 21 23 21 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 49 57 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;</italic>
###xml 57 59 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 57 59 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 63 70 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">decorin</italic>
###xml 0 70 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Annual decline in FEV<sub>1 </sub>according to genotypes of <italic>TGF-&#946;</italic><sub><italic>1 </italic></sub>and <italic>decorin</italic></bold>
Annual decline in FEV1 according to genotypes of TGF-beta1 and decorin. Changes in decline between genotypes in never smokers and current and past smokers are presented.
###end p 67
###begin p 68
Click here for file
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
This study was funded by the Netherlands Asthma Foundation, grant 3.2.02.51.
###end p 70
###begin article-title 71
Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD
###end article-title 71
###begin article-title 72
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease
###end article-title 72
###begin article-title 73
Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease
###end article-title 73
###begin article-title 74
Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5
###end article-title 74
###begin article-title 75
Decorin-type I collagen interaction. Presence of separate core protein-binding domains
###end article-title 75
###begin article-title 76
Collagen phagocytosis by fibroblasts is regulated by decorin
###end article-title 76
###begin article-title 77
Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function
###end article-title 77
###begin article-title 78
Negative regulation of transforming growth factor-beta by the proteoglycan decorin
###end article-title 78
###begin article-title 79
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema
###end article-title 79
###begin article-title 80
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema
###end article-title 80
###begin article-title 81
Factors associated with bronchial responsiveness to histamine in a population sample of adults
###end article-title 81
###begin article-title 82
Longterm exposure to air pollution and decline in VC and FEV1. Recent results from a longitudinal epidemiologic study in the Netherlands
###end article-title 82
###begin article-title 83
The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology)
###end article-title 83
###begin article-title 84
The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)
###end article-title 84
###begin article-title 85
Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population
###end article-title 85
###begin article-title 86
Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease
###end article-title 86
###begin article-title 87
The International HapMap Project
###end article-title 87
###begin article-title 88
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update
###end article-title 88
###begin article-title 89
A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population
###end article-title 89
###begin article-title 90
Longitudinal analyses of airway responsiveness and pulmonary function decline
###end article-title 90
###begin article-title 91
Transforming Growth Factor-< beta ><inf>1</inf> Promoter Polymorphism C-509T Is Associated with Asthma
###end article-title 91
###begin article-title 92
Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma
###end article-title 92
###begin article-title 93
Genetic control of the circulating concentration of transforming growth factor type beta1
###end article-title 93
###begin article-title 94
Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
###end article-title 94
###begin article-title 95
Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release
###end article-title 95
###begin article-title 96
###xml 146 151 <span type="species:ncbi:9606">human</span>
Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts
###end article-title 96

